Year: 2023
Type: erratum
Abstract: An error was brought to our attention on the initial online version (10 november 2022), which was reported for correction on 01 December 2022.When discussing the dosage of trastuzumab deruxtecan, the intial paper incorrectly cites the dosage of 6.4mg/Kg.It should be corrected to « blinded 6.4 or 5.4mg/Kg ».Listed below are where the corrections have been made: Page 2 "After screening, including a cardiac evaluation revealing no morphologic or functional alterations, treatment was started at blided dose 6.4 mg/kg or 5.4 mk/kg every 3 weeks in October 2021."
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W4386016625